Skip to content

Clinical trials

Multiple Chronic Conditions trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Chronic Conditions Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20122
20131
20142
20161
20181
20195
20207
20215
202210
20236
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting7
Active, not recruiting5
Unknown status3
Not yet recruiting1
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Alabama at Birmingham4
University of Utah4
University of North Carolina, Chapel Hill3
VA Office of Research and Development3
Innovation Research & Training2
University Hospitals Cleveland Medical Center2
University of Wisconsin, Madison2
Brigham and Women's Hospital1
Children's Hospital Los Angeles1
Documenting Hope Project1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Chronic Conditions51
Chronic Disease7
Diabetes Mellitus4
Hypertension3
Dementia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Obesity2
Burnout, Professional1
Cardiovascular Diseases1

Trials

Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.